Navigation Links
Advil or Excedrin? New model helps predict product choices
Date:5/30/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... from LSTM have called for more research to ... in children in sub-Saharan Africa. In a paper ... Professor Russell Stothard, working with colleagues in the ... Reserve University, in Cleveland Ohio, University of Cambridge ... research into the joint burden of HIV/AIDS and ...
(Date:4/16/2014)... (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) ... study of CDX-1401 in solid tumors, including long-term patient ... (Vol 6 Issue 232). The data demonstrate robust ... benefit in patients with very advanced cancers and suggest ...
(Date:4/16/2014)... treatments are the leading cause of increases in multiple ... premature birth, these results are not inevitable, concludes an ... The article identifies six changes in policy and practice ... prematurity, including expanding insurance coverage for in vitro fertilization ...
(Date:4/15/2014)... CHAMPAIGN, Ill. Scientists have solved a decades-old medical mystery ... to fight invasive fungal infections, which kill about 1.5 million people ... action of amphotericin, an antifungal drug that has been in use ... as toxic to human cells as it is to the microbes ...
(Date:4/14/2014)... in chemotherapy over the past decade, but targeting drugs ... be a major challenge. , Nanotechnology has unlocked ... of nanocarriers, or capsules, that can transport cargoes of ... The catch? These carriers are tiny, and it matters ...
Breaking Medicine News(10 mins):Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Nano shake-up 2
... The World Bank, whose website (www.worldbank.org) declares "Our dream ... construction of private hospital in Mumbai, India, a move ... using development assistance for projects that will mainly benefit ... of Maharashtra state an International Development Association loan of ...
... risk pregnancies, who live in the developing nations, can safely cut ... 6 times during pregnancy instead of the prescribed 8 - 11 ... not more at risk than women who had more prenatal visits ... pregnancy, or spend longer in the hospital than women who had ...
... Africa make it more difficult for the anti AIDS drugs to ... that these drugs will be powerless against the virus but these ... is an enzyme useful in the replication of the virus inside ... then it is easier for the drug to deactivate the virus. ...
... literature on the accuracy of penicillin allergies has come ... people who claim that they are allergic to penicillin ... to the drug. ,The researchers led by Dr. ... the University of Missouri-Kansas City School of Medicine, say ...
... one of the worst types of chronic pain. Many ... condition. But now there’s good news for the long-suffering ... most popular forms of alternative medicine, is supposed to ... ,A team led by Dr. Jeanette Ezzo, Washington, DC, ...
... London's Middlesex Hospital, advices passengers, who fly long haul flights, that ... on board an airliner, while she was flying a long distance ... be fatal to many people. ,Dr. Scurr says this fear ... clot formation can also occur if a person spends long hours ...
Cached Medicine News:Health News:The World Bank funds private Hospital in India 2Health News:Patients often assume wrongly that they are allergic to penicillin 2
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... Jan. 15, 2014  A novel wearable injector slightly larger than ... for patients to self-inject prescription drugs in the large doses ... blood diseases, autoimmune deficiencies, and genetic disorders.  ... $220B by 2018, according to analysts.   Many of these drugs ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... N.J., Feb. 22, 2011 Covance Inc. (NYSE: ... 2nd Annual Morningstar/NYSSA Healthcare Conference on Thursday, February 24, 2011 ... of the presentation at www.covance.com .  In order to ... minutes early. Covance, with headquarters in Princeton, New ...
... Telik, Inc. (Nasdaq: TELK ) reported a net loss ... ended December 31, 2010, compared with a net loss of $4.2 ...  For the year ended December 31, 2010, net loss was $24.7 ... $23.7 million, or $0.44 per share, for the year ended December ...
Cached Medicine Technology:Covance to Present at the 2nd Annual Morningstar/NYSSA Healthcare Conference 2Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 2Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 3Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 4Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: